<DOC>
	<DOC>NCT01556802</DOC>
	<brief_summary>The investigators will evaluate the National Institute of Health Stroke Scale/Score (NIHSS)in patients with stroke, and then give Minocycline 100mg po every 12 hours or placebo for five days, then perform periodic evaluations to determine the status and degree of neurological sequelae developed.</brief_summary>
	<brief_title>Use of Minocicline in Patients With Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<criteria>NIHSS scale greater than 5 Onset of symptoms less than 24 hours normal Cranial Tomography(CT) CT evidence of cerebral ischemia Acceptance of study entry Hemorrhagic cerebrovascular disease Other neurological diseases Concomitant structural damage History of neurosurgery Known allergy to tetracyclines Concomitant infectious diseases requiring antibiotic treatment. History of Stroke Women pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>stroke</keyword>
	<keyword>sequelaes</keyword>
	<keyword>minocicline</keyword>
</DOC>